Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix gla protein

Journal of Biological Chemistry

Volumn 288, Issue 4, 2013, Pages 2632-2640

  Beazley, Kelly E ^a   Eghtesad, Saman ^a   Nurminskaya, Maria V ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTIC RINGS; CATENIN SIGNALING; DOWN-REGULATION; GLYCOGEN SYNTHASE KINASE-3; IN-VITRO; INHIBITORY EFFECT; MECHANISM OF ACTION; PHOSPHATE LEVELS; THERAPEUTIC LEVELS; VASCULAR CALCIFICATION; VASCULAR SMOOTH MUSCLE CELLS;

ACTIVATION ANALYSIS; BIOMINERALIZATION; BONE; CARBOXYLATION; FATTY ACIDS; PHENOLS; PROTEINS;

FLAVONOIDS;

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CALCIUM; CCAAT ENHANCER BINDING PROTEIN BETA; COLLAGEN TYPE 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; OSTEOCALCIN; OSTEOPONTIN; QUERCETIN; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; WARFARIN;

ALKALINE PHOSPHATASE GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE DEVELOPMENT; CALCIUM METABOLISM; CARBOXYLATION; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; EMBRYO; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERFERON GAMMA GENE; INTERLEUKIN 1BETA GENE; INTRACELLULAR SIGNALING; MALE; MSX2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCALCIN GENE; OSTEOPONTIN GENE; OSX GENE; PHOSPHATE TRANSPORTER 1 GENE; PIT 1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RUNX2 GENE; TUMOR NECROSIS FACTOR ALPHA GENE; TYPE 1 COLLAGEN GENE; UPREGULATION; VASCULAR RING;

ANIMALS; ANTIOXIDANTS; AORTA; BETA CATENIN; CALCIUM-BINDING PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENES, REPORTER; LUCIFERASES; MUSCLE, SMOOTH, VASCULAR; QUERCETIN; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION; WARFARIN;

EID: 84873836228     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.368639     Document Type: Article

References (57)

1. Johnson, R. C., Leopold, J. A., and Loscalzo, J. (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ. Res. 99, 1044-1059
2. Demer, L. L., and Tintut, Y. (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117, 2938-2948
3. Lerner, R. G., Aronow, W. S., Sekhri, A., Palaniswamy, C., Ahn, C., Singh, T., Sandhu, R., and McClung, J. A. (2009) Warfarin use and the risk of valvular calcification. J. Thromb. Haemost. 7, 2023-2027
4. Rennenberg, R. J., van Varik, B. J., Schurgers, L. J., Hamulyak, K., Ten Cate, H., Leiner, T., Vermeer, C., de Leeuw, P. W., and Kroon, A. A. (2010) Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood 115, 5121-5123
5. Price, P. A., Faus, S. A., and Williamson, M. K. (1998) Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 18, 1400-1407
6. Essalihi, R., Dao, H. H., Yamaguchi, N., and Moreau, P. (2003) A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am. J. Hypertens. 16, 103-110
7. Iyemere, V. P., Proudfoot, D., Weissberg, P. L., and Shanahan, C. M. (2006) Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J. Intern. Med. 260, 192-210
8. Byon, C. H., Javed, A., Dai, Q., Kappes, J. C., Clemens, T. L., Darley-Usmar, V. M., McDonald, J. M., and Chen, Y. (2008) Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J. Biol. Chem. 283, 15319-15327
9. Shanahan, C. M., Crouthamel, M. H., Kapustin, A., and Giachelli, C. M. (2011) Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ. Res. 109, 697-711
10. Rutsch, F., Nitschke, Y., and Terkeltaub, R. (2011) Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ. Res. 109, 578-592
11. Lomashvili, K. A., Wang, X., Wallin, R., and O'Neill, W. C. (2011) Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification. J. Biol. Chem. 286, 28715-28722
12. O'Young, J., Liao, Y., Xiao, Y., Jalkanen, J., Lajoie, G., Karttunen, M., Goldberg, H. A., and Hunter, G. K. (2011) Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J. Am. Chem. Soc. 133, 18406-18412
13. Boström, K., Tsao, D., Shen, S., Wang, Y., and Demer, L. L. (2001) Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J. Biol. Chem. 276, 14044-14052
14. Zebboudj, A. F., Imura, M., and Boström, K. (2002) Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J. Biol. Chem. 277, 4388-4394
15. Schurgers, L. J., Spronk, H. M., Skepper, J. N., Hackeng, T. M., Shanahan, C. M., Vermeer, C., Weissberg, P. L., and Proudfoot, D. (2007) Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J. Thromb. Haemost. 5, 2503-2511
16. Speer, M. Y., Yang, H. Y., Brabb, T., Leaf, E., Look, A., Lin, W. L., Frutkin, A., Dichek, D., and Giachelli, C. M. (2009) Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ. Res. 104, 733-741
17. Yao, Y., Bennett, B. J., Wang, X., Rosenfeld,M.E., Giachelli, C., Lusis, A. J., and Boström, K. I. (2010) Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ. Res. 107, 485-494
18. Beazley, K. E., Deasey, S., Lima, F., and Nurminskaya, M. V. (2012) Transglutaminase 2-mediated activation of α-catenin signaling has a critical role in warfarin-induced vascular calcification. Arterioscler. Thromb. Vasc. Biol. 32, 123-130
19. Han, W., Wang, W., Mohammed, K. A., and Su, Y. (2009) α-Defensins increase lung fibroblast proliferation and collagen synthesis via the α-catenin signaling pathway. FEBS J. 276, 6603-6614
20. Shan, B. E., Wang, M. X., and Li, R. Q. (2009) Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/α-catenin signaling pathway. Can- cer Invest. 27, 604-612
21. Park, C. H., Chang, J. Y., Hahm, E. R., Park, S., Kim, H. K., and Yang, C. H. (2005) Quercetin, a potent inhibitor against α-catenin/Tcf signaling in SW480 colon cancer cells. Biochem. Biophys. Res. Commun. 328, 227-234
22. Huang, M. S., Sage, A. P., Lu, J., Demer, L. L., and Tintut, Y. (2008) Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification. Biochem. Biophys. Res. Commun. 374, 553-558
23. Tintut, Y., Parhami, F., Boström, K., Jackson, S. M., and Demer, L. L. (1998) cAMP stimulates osteoblast-like differentiation of calcifying vascular cells: potential signaling pathway for vascular calcification. J. Biol. Chem. 273, 7547-7553
24. Hoppler, S., and Moon, R. T. (1998) BMP-2/-4 and Wnt-8 cooperatively pattern the Xenopus mesoderm. Mech. Dev. 71, 119-129
25. Handrigan, G. R., and Richman, J. M. (2010) A network of Wnt, hedgehog, and BMP signaling pathways regulates tooth replacement in snakes. Dev. Biol. 348, 130-141
26. Wan, M., Yang, C., Li, J., Wu, X., Yuan, H., Ma, H., He, X., Nie, S., Chang, C., and Cao, X. (2008) Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev. 22, 2968-2979
27. Zhao, L., Li, G., and Zhou, G. Q. (2009) SOX9 directly binds CREB as a novel synergism with the PKA pathway in BMP-2-induced osteochondrogenic differentiation. J. Bone Miner. Res. 24, 826-836
28. Lomashvili, K. A., Cobbs, S., Hennigar, R. A., Hardcastle, K. I., and O'Neill, W. C. (2004) Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J. Am. Soc. Nephrol. 15, 1392-1401
29. Jono, S., McKee, M. D., Murry, C. E., Shioi, A., Nishizawa, Y., Mori, K., Morii, H., and Giachelli, C. M. (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 87, E10-E17
30. Osinbowale, O., Al Malki, M., Schade, A., and Bartholomew, J. R. (2009) An algorithm for managing warfarin resistance. Cleve. Clin. J. Med. 76, 724-730
31. Alcocer, F., Whitley, D., Salazar-Gonzalez, J. F., Jordan, W. D., Sellers, M. T., Eckhoff, D. E., Suzuki, K., Macrae, C., and Bland, K. I. (2002) Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery 131, 198-204
32. Perez-Vizcaino, F., Bishop-Bailley, D., Lodi, F., Duarte, J., Cogolludo, A., Moreno, L., Bosca, L., Mitchell, J. A., and Warner, T. D. (2006) The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 346, 919-925
33. Giachelli, C. M., Speer, M. Y., Li, X., Rajachar, R. M., and Yang, H. (2005) Regulation of vascular calcification: roles of phosphate and osteopontin. Circ. Res. 96, 717-722
34. Jahnen-Dechent, W., Schäfer, C., Ketteler, M., and McKee, M. D. (2008) Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J. Mol. Med. 86, 379-389
35. Yamaguchi, A., Komori, T., and Suda, T. (2000) Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 21, 393-411
36. Al-Aly, Z., Shao, J. S., Lai, C. F., Huang, E., Cai, J., Behrmann, A., Cheng, S. L., and Towler, D. A. (2007) Aortic Msx2-Wnt calcification cascade is regulated by TNF-α-dependent signals in diabetic Ldlr-/- mice. Arterioscler. Thromb. Vasc. Biol. 27, 2589-2596
37. Gordon, M. D., and Nusse, R. (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 281, 22429-22433
38. Chatrou, M. L., Reutelingsperger, C. P., and Schurgers, L. J. (2011) Role of vitamin K-dependent proteins in the arterial vessel wall. Hamostaseologie 31, 251-257
39. Boström, K. I., Rajamannan, N. M., and Towler, D. A. (2011) The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ. Res. 109, 564-577
40. Shimizu, T., Tanaka, T., Iso, T., Matsui, H., Ooyama, Y., Kawai-Kowase, K., Arai, M., and Kurabayashi, M. (2011) Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells. J. Biol. Chem. 286, 19138-19148
41. Shao, J. S., Cheng, S. L., Pingsterhaus, J. M., Charlton-Kachigian, N., Loewy, A. P., and Towler, D. A. (2005) Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J. Clin. Invest. 115, 1210-1220
42. Rajamannan, N. M. (2011) The role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory. J. Cell. Biochem. 112, 2222-2229
43. Ichida, F., Nishimura, R., Hata, K., Matsubara, T., Ikeda, F., Hisada, K., Yatani, H., Cao, X., Komori, T., Yamaguchi, A., and Yoneda, T. (2004) Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J. Biol. Chem. 279, 34015-34022
44. Matsuguchi, T., Chiba, N., Bandow, K., Kakimoto, K., Masuda, A., and Ohnishi, T. (2009) JNK activity is essential for Atf4 expression and latestage osteoblast differentiation. J. Bone Miner. Res. 24, 398-410
45. Beck, G. R., Jr., Zerler, B., and Moran, E. (2000) Phosphate is a specific signal for induction of osteopontin gene expression. Proc. Natl. Acad. Sci. U.S.A. 97, 8352-8357
46. Shao, J. S., Aly, Z. A., Lai, C. F., Cheng, S. L., Cai, J., Huang, E., Behrmann, A., and Towler, D. A. (2007) Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann. N.Y. Acad. Sci. 1117, 40-50
47. Hsu, J. J., Lu, J., Huang, M. S., Geng, Y., Sage, A. P., Bradley, M. N., Tontonoz, P., Demer, L. L., and Tintut, Y. (2009) T0901317, an LXR agonist, augments PKA-induced vascular cell calcification. FEBS Lett. 583, 1344-1348
48. Schurgers, L. J., Spronk, H. M., Soute, B. A., Schiffers, P. M., DeMey, J. G., and Vermeer, C. (2007) Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 109, 2823-2831
49. Rulcova, A., Prokopova, I., Krausova, L., Bitman, M., Vrzal, R., Dvorak, Z., Blahos, J., and Pavek, P. (2010) Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes. J. Thromb. Haemost. 8, 2708-2717
50. Faverman, L., Mikhaylova, L., Malmquist, J., and Nurminskaya, M. (2008) Extracellular transglutaminase 2 activatesα-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett. 582, 1552-1557
51. Terao, J. (2009) Dietary flavonoids as antioxidants. Forum Nutr. 61, 87-94
52. Dao, H. H., Essalihi, R., Graillon, J. F., Larivière, R., De Champlain, J., and Moreau, P. (2002) Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension. J. Hypertens. 20, 1597-1606
53. Mikhaylova, L., Malmquist, J., and Nurminskaya, M. (2007) Regulation of in vitro vascular calcification by BMP4, VEGF, and Wnt3a. Calcif. Tissue Int. 81, 372-381
54. Carlson, M. E., Silva, H. S., and Conboy, I. M. (2008) Aging of signal transduction pathways, and pathology. Exp. Cell Res. 314, 1951-1961
55. Huxley, R. R., and Neil, H. A. (2003) The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 57, 904-908
56. Edwards, R. L., Lyon, T., Litwin, S. E., Rabovsky, A., Symons, J. D., and Jalili, T. (2007) Quercetin reduces blood pressure in hypertensive subjects. J. Nutr. 137, 2405-2411
57. Harwood, M., Danielewska-Nikiel, B., Borzelleca, J. F., Flamm, G. W., Williams, G. M., and Lines, T. C. (2007)Acritical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 45, 2179-2205